Momentus narrows loss 13%, remedies control weakness, but cash burn accelerates

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 1, 2025 · ~2 min read

Key Changes

• high

  Going-concern status improved: cash rose to $12.8M from $1.6M and management now concludes mitigation plans alleviate substantial doubt, versus prior year's unqualified substantial doubt. Company raised $34.6M in 2025 financing.

  MD&A: Going Concern verify on EDGAR →
• high

  Material weakness in internal controls over financial reporting (misclassification errors) fully remediated during Q4 2025; disclosure controls and internal controls now deemed effective.

  Controls & Procedures verify on EDGAR →
• high

  Vigoride enhancements underway to expand operational envelope from LEO to GEO, Lunar, and Deep Space orbits; U.S. Space Force awarded Direct to Phase II SBIR contract for RPO demonstration in early 2026.

  Business: Expanded Orbit Capabilities verify on EDGAR →